CompoAtlas

HONGJITANG JUHONG PILL

HONGJITANG JUHONG PILL : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Citrus grandisCitrus grandis[356.9 mg,6000 mg]Not identified
Citrus reticulataCitrus reticulata[237.6 mg,6000 mg]Not identified
Pinelliae TernataPinelliae Ternata[178.5 mg,6000 mg]Not identified
Poria cocosPoria cocos[237.6 mg,6000 mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[119.3 mg,6000 mg]Not identified
Platycodon grandiflorumPlatycodon grandiflorum[178.5 mg,6000 mg]Not identified
Prunus armeniacaPrunus armeniaca[237.6 mg,6000 mg]Not identified
Perilla frutescensPerilla frutescens[178.4 mg,6000 mg]Not identified
Aster tataricusAster tataricus[178.4 mg,6000 mg]Not identified
Tussilago farfaraTussilago farfara[119.3 mg,6000 mg]Not identified
Trichosanthes kirilowiiTrichosanthes kirilowii[237.6 mg,6000 mg]Not identified
Fritillaria thunbergiiFritillaria thunbergii[237.6 mg,6000 mg]Not identified
Rehmannia glutinosaRehmannia glutinosa[237.6 mg,6000 mg]Not identified
Ophiopogon japonicusOphiopogon japonicus[237.6 mg,6000 mg]Not identified
Gypsum fibrosumGypsum fibrosum[237.6 mg,6000 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL19036079T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
HAI-O MEDICINE SDN. BHD.
Manufacturer
Shandong Hongjitang Pharmaceutical Group Co., Ltd.
Importer
HAI-O MEDICINE SDN. BHD.
Registration period starting
2024-03-14
Published validity end
2029-03-14

Original register data

View published fields and their variants
Active ingredients
Citrus grandis[356.9 mg,6000 mg],Citrus reticulata[237.6 mg,6000 mg],Pinelliae Ternata[178.5 mg,6000 mg],Poria cocos[237.6 mg,6000 mg],Glycyrrhiza uralensis[119.3 mg,6000 mg],Platycodon grandiflorum[178.5 mg,6000 mg],Prunus armeniaca[237.6 mg,6000 mg],Perilla frutescens[178.4 mg,6000 mg],Aster tataricus[178.4 mg,6000 mg],Tussilago farfara[119.3 mg,6000 mg],Trichosanthes kirilowii[237.6 mg,6000 mg],Fritillaria thunbergii[237.6 mg,6000 mg],Rehmannia glutinosa[237.6 mg,6000 mg],Ophiopogon japonicus[237.6 mg,6000 mg],Gypsum fibrosum[237.6 mg,6000 mg]
Valid until
2029-03-14
Registration date
2024-03-14
Published description
NATURAL PRODUCT
Licence holder
HAI-O MEDICINE SDN. BHD.
Importer
HAI-O MEDICINE SDN. BHD.
Producer
Shandong Hongjitang Pharmaceutical Group Co., Ltd.
Published name
HONGJITANG JUHONG PILL
Published reference
201808090843T
Registration number
MAL19036079T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL19036079T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    Sources cited by Health Canada (1)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    Sources cited by Health Canada (2)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “HONGJITANG JUHONG PILL”, https://compoatlas.com/en/supplements/malaysia/MAL19036079T-hongjitang-juhong-pill, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line